HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Haleon Supports EU Packaging Proposals But Has ‘Serious Concerns’ About Timings

Executive Summary

Haleon says it “supports the overall ambitions” of the European Commission’s proposals for a new Regulation on Packaging and Packaging Waste, but has “serious concerns” about the timelines established in the proposal, for example that all medicines packaging should be recyclable by 2035.

You may also be interested in...



Packaging Experts On Luxury Beauty’s Unique Sustainability Challenges

Consumers increasingly prize sustainable packaging, but that doesn’t mean they’ll necessarily accept compromises in aesthetics and functionality, particularly in the luxury beauty space. Experts from Marc Rosen Associates and Eastman Chemical discuss.

Haleon And Sanofi Back PulPac’s Plastic-Free Bottle Prototype

Sanofi Consumer Healthcare and Haleon have joined a partnership to scale up the manufacture of PulPac's dry molded fiber, plastic-free bottle prototype.

EU Packaging Regulation Presents Challenge And Opportunity For Consumer Health Industry

A proposed new European Union packaging regulation, which introduces environmental and labelling requirements and extended producer responsibility for medicines, medical devices and food supplements, could be challenging for the region's consumer health industry. But it could also be a spur to creativity, argues Chris Whitehouse, chairman and managing director of Whitehouse Communications.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153584

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel